With an increasing trend towards personalised medicines, cell and gene therapies expected in Australia [ 66 ], this may create challenges for timely reimbursement and availability of new cutting-edge therapies.
1
—
—
With an increasing trend towards personalised medicines, cell and gene therapies expected in Australia [ 66 ], this may create challenges for timely reimbursement and availability of new cutting-edge therapies.